WuXi Biologics
Offering End-to-End Solutions
Antibody-oligonucleotide conjugates (AOCs) unite antibody specificity with the gene-silencing power of oligonucleotides for targeted delivery of nucleic acid therapeutics. WuXi XDC accelerates AOC development with fully integrated services, combining biologics and oligo expertise with advanced conjugation and analytical capabilities to streamline your journey from concept to clinic. |
Discuss This Service Overview
To discuss the information in this service overview, please complete the form on the following page to connect with our experts.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?